These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 25855851)
1. Topical platelet-derived growth factor vs placebo therapy of diabetic foot ulcers offloaded with windowed casts: a randomized, controlled trial. Ma C; Hernandez MA; Kirkpatrick VE; Liang LJ; Nouvong AL; Gordon II Wounds; 2015 Apr; 27(4):83-91. PubMed ID: 25855851 [TBL] [Abstract][Full Text] [Related]
2. Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study. Richard JL; Parer-Richard C; Daures JP; Clouet S; Vannereau D; Bringer J; Rodier M; Jacob C; Comte-Bardonnet M Diabetes Care; 1995 Jan; 18(1):64-9. PubMed ID: 7698050 [TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers. Steed DL Plast Reconstr Surg; 2006 Jun; 117(7 Suppl):143S-149S; discussion 150S-151S. PubMed ID: 16799381 [TBL] [Abstract][Full Text] [Related]
4. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration. O'Meara S; Cullum N; Majid M; Sheldon T Health Technol Assess; 2000; 4(21):1-237. PubMed ID: 11074391 [TBL] [Abstract][Full Text] [Related]
5. The effect of short-contact topical tretinoin therapy for foot ulcers in patients with diabetes. Tom WL; Peng DH; Allaei A; Hsu D; Hata TR Arch Dermatol; 2005 Nov; 141(11):1373-7. PubMed ID: 16301384 [TBL] [Abstract][Full Text] [Related]
6. The effect of PDRN, an adenosine receptor A2A agonist, on the healing of chronic diabetic foot ulcers: results of a clinical trial. Squadrito F; Bitto A; Altavilla D; Arcoraci V; De Caridi G; De Feo ME; Corrao S; Pallio G; Sterrantino C; Minutoli L; Saitta A; Vaccaro M; Cucinotta D J Clin Endocrinol Metab; 2014 May; 99(5):E746-53. PubMed ID: 24483158 [TBL] [Abstract][Full Text] [Related]
7. Fibreglass Total Contact Casting, Removable Cast Walkers, and Irremovable Cast Walkers to Treat Diabetic Neuropathic Foot Ulcers: A Health Technology Assessment. Health Quality Ontario Ont Health Technol Assess Ser; 2017; 17(12):1-124. PubMed ID: 28989556 [TBL] [Abstract][Full Text] [Related]
8. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. Steed DL; Donohoe D; Webster MW; Lindsley L J Am Coll Surg; 1996 Jul; 183(1):61-4. PubMed ID: 8673309 [TBL] [Abstract][Full Text] [Related]
9. Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers. Niezgoda JA; Van Gils CC; Frykberg RG; Hodde JP Adv Skin Wound Care; 2005 Jun; 18(5 Pt 1):258-66. PubMed ID: 15942317 [TBL] [Abstract][Full Text] [Related]
10. Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers. Hanft JR; Pollak RA; Barbul A; van Gils C; Kwon PS; Gray SM; Lynch CJ; Semba CP; Breen TJ J Wound Care; 2008 Jan; 17(1):30-2, 34-7. PubMed ID: 18210954 [TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic plantar ulcer of the diabetic foot using an irremovable windowed fibreglass cast boot: prospective study of 177 patients. Ha Van G; Michaux C; Parquet H; Bourron O; Pradat-Diehl P; Hartemann A Diabetes Metab Res Rev; 2015 Oct; 31(7):691-8. PubMed ID: 25941091 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Wieman TJ; Smiell JM; Su Y Diabetes Care; 1998 May; 21(5):822-7. PubMed ID: 9589248 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of ozone-oxygen therapy for the treatment of diabetic foot ulcers. Wainstein J; Feldbrin Z; Boaz M; Harman-Boehm I Diabetes Technol Ther; 2011 Dec; 13(12):1255-60. PubMed ID: 21751891 [TBL] [Abstract][Full Text] [Related]
14. Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study. Kalani M; Apelqvist J; Blombäck M; Brismar K; Eliasson B; Eriksson JW; Fagrell B; Hamsten A; Torffvit O; Jörneskog G Diabetes Care; 2003 Sep; 26(9):2575-80. PubMed ID: 12941721 [TBL] [Abstract][Full Text] [Related]
15. Randomized single-blind trial of topical ketanserin for healing acceleration of diabetic foot ulcers. Martínez-de Jesús FR; Morales-Guzmán M; Castañeda M; Pérez-Morales A; García-Alonso J; Mendiola-Segura I Arch Med Res; 1997; 28(1):95-9. PubMed ID: 9078595 [TBL] [Abstract][Full Text] [Related]
16. Peak foot pressures influence the healing time of diabetic foot ulcers treated with total contact casts. Armstrong DG; Lavery LA; Bushman TR J Rehabil Res Dev; 1998 Jan; 35(1):1-5. PubMed ID: 9505247 [TBL] [Abstract][Full Text] [Related]
17. Advanced biological therapies for diabetic foot ulcers. Kirsner RS; Warriner R; Michela M; Stasik L; Freeman K Arch Dermatol; 2010 Aug; 146(8):857-62. PubMed ID: 20713816 [TBL] [Abstract][Full Text] [Related]
18. Human epidermal growth factor enhances healing of diabetic foot ulcers. Tsang MW; Wong WK; Hung CS; Lai KM; Tang W; Cheung EY; Kam G; Leung L; Chan CW; Chu CM; Lam EK Diabetes Care; 2003 Jun; 26(6):1856-61. PubMed ID: 12766123 [TBL] [Abstract][Full Text] [Related]
19. [Approval for recombinant growth factor. Since January 2000, patients with diabetic foot ulcers can be treated with the growth factor becaplermin (Regranex), manufactured with genetic technology]. Fruhstorfer B Internist (Berl); 2000 Jan; 41(1):A38. PubMed ID: 10712088 [No Abstract] [Full Text] [Related]
20. Electric stimulation as an adjunct to heal diabetic foot ulcers: a randomized clinical trial. Peters EJ; Lavery LA; Armstrong DG; Fleischli JG Arch Phys Med Rehabil; 2001 Jun; 82(6):721-5. PubMed ID: 11387573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]